Spinal Injections in Immunosuppressed Patients and the Risks Associated with Procedural Care: To Inject or Not to Inject?

Myth: Spinal injections in immunosuppressed patients have been proven to increase the incidence of periprocedural infections and complications. Learn about the facts surrounding this myth and the best practices to support safe performance of interventional pain procedures in your practice.

Each participant will read the FactFinder and will answer post-test questions to earn continuing medical education (CME) credits.

Authors
Adrian Popescu, MD; Jaymin Patel, MD; and Clark C. Smith, MD on behalf of the Spine Intervention Society’s Patient Safety Committee.

Copyright
Materials presented in this activity have been made available by the Spine Intervention Society for educational purposes only. We reserve all rights to such material.

Educational Objectives
Upon completion of this activity, participants should be able to:

• Identify best practices to ensure patient safety during interventional spine procedures
• Cite the evidentiary basis for risk mitigation strategies in the safe performance of interventional pain procedures

Author Disclosures Information
RELEVANT FINANCIAL RELATIONSHIPS WITH ACCME DEFINED COMMERCIAL INTERESTS
Adrian Popescu, MD
Nothing to disclose

Jaymin Patel, MD
Nothing to disclose

Clark C. Smith, MD
Nothing to disclose

OTHER DISCLOSURES
Adrian Popescu, MD
Nothing to disclose

Jaymin Patel, MD
Nothing to disclose

Clark C. Smith, MD 
Nothing to disclose

Accreditation Statement
The Spine Intervention Society (SIS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
SIS designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Activity Release: 1/9/2019
Date of Activity Expiration: 1/8/2022